Used primarily in pharmaceutical research for the development of CNS-targeted therapeutics. Its structure supports blood-brain barrier penetration and interaction with central nervous system receptors, including neurotransmitter receptors. Shows potential in neurodegenerative disease research and psychiatric disorders such as depression, anxiety, and psychosis due to its ability to modulate relevant signaling pathways. Serves as a key intermediate or model compound in designing selective drugs with improved potency, selectivity, and reduced side effects. Commonly employed in structure-activity relationship (SAR) studies. Currently in laboratory or preclinical stages, not yet widely used clinically.